Poly Medicure Limited has successfully completed the acquisition of Brazilian medical device company MEDYNEO COMERCIO DE PRODUTOS PARA SAUDE LTDA through its wholly owned subsidiary Polymed Brazil LTDA. The transaction was finalized on April 29, 2026, with the company receiving information about the completion on April 30, 2026.

Acquisition Structure and Timeline

Polymed Brazil LTDA executed a Quota Purchase Agreement on April 29, 2026, acquiring 100% equity in MEDYNEO from its existing quotaholders. The acquisition process was completed on the same day, with Polymed Brazil LTDA taking operational control of MEDYNEO, making it a step-down subsidiary of Poly Medicure Limited.

Target Company Profile

MEDYNEO COMERCIO DE PRODUTOS PARA SAUDE LTDA is a Brazilian limited liability company focused on the importation and commercialization of medical devices. The company was incorporated on July 24, 2025, and operates as a shell entity without past activities, operations, employees, or existing liabilities.

Strategic Rationale

The acquisition provides Poly Medicure with crucial market access capabilities in Brazil's medical device sector. MEDYNEO holds all necessary licenses, permits, and registrations required for legal operation in Brazil's medical device importation and commercialization business segment. This licensing framework enables Polymed Brazil LTDA to immediately commence commercial operations without the typical regulatory approval delays.

Regulatory Compliance

The transaction does not constitute a related party transaction, with no promoter or group company interests in the acquired entity. The acquisition required no governmental or regulatory approvals, streamlining the completion process. The company has disclosed the transaction under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, ensuring full regulatory compliance.

Market Expansion Impact

This acquisition represents Poly Medicure's strategic entry into the Brazilian medical device market through a clean corporate structure. By acquiring a company with established licensing but no operational history or liabilities, Poly Medicure gains immediate market access while maintaining operational flexibility for future business development in Brazil's growing healthcare sector.

Poly Medicure Limited has submitted its quarterly compliance certificate to stock exchanges, fulfilling regulatory requirements under SEBI's depositories regulations for the quarter ended March 31, 2026.

Regulatory Compliance Filing

The company filed the mandatory certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 on April 15, 2026. The submission was made to both BSE Limited and National Stock Exchange of India Limited through Company Secretary Avinash Chandra.

Registrar Confirmation

MAS Services Limited, serving as the company's Registrar & Share Transfer Agent, provided the confirmation certificate dated April 2, 2026. The registrar confirmed compliance with all dematerialization requirements during the specified quarter.

The registrar's certificate verified that:

• All securities received from Depository Participants for dematerialization were confirmed within 15 days of receipt
• Security certificates were properly mutilated and cancelled after due verification
• Depositories were substituted as registered owners in the member register within the mandated timeline
• Register of Members was updated accordingly

Process Compliance

The filing demonstrates the company's adherence to SEBI's regulatory framework governing depositories and participants, ensuring proper handling of securities dematerialization processes during the quarter ended March 31, 2026.